Skip Navigation

Publication Detail

Title: Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.

Authors: Shen, Hua; McHale, Cliona M; Smith, Martyn T; Zhang, Luoping

Published In Mutat Res Rev Mutat Res, (2015)

Abstract: Characterizing variability in the extent and nature of responses to environmental exposures is a critical aspect of human health risk assessment. Chemical toxicants act by many different mechanisms, however, and the genes involved in adverse outcome pathways (AOPs) and AOP networks are not yet characterized. Functional genomic approaches can reveal both toxicity pathways and susceptibility genes, through knockdown or knockout of all non-essential genes in a cell of interest, and identification of genes associated with a toxicity phenotype following toxicant exposure. Screening approaches in yeast and human near-haploid leukemic KBM7 cells have identified roles for genes and pathways involved in response to many toxicants but are limited by partial homology among yeast and human genes and limited relevance to normal diploid cells. RNA interference (RNAi) suppresses mRNA expression level but is limited by off-target effects (OTEs) and incomplete knockdown. The recently developed gene editing approach called clustered regularly interspaced short palindrome repeats-associated nuclease (CRISPR)-Cas9, can precisely knock-out most regions of the genome at the DNA level with fewer OTEs than RNAi, in multiple human cell types, thus overcoming the limitations of the other approaches. It has been used to identify genes involved in the response to chemical and microbial toxicants in several human cell types and could readily be extended to the systematic screening of large numbers of environmental chemicals. CRISPR-Cas9 can also repress and activate gene expression, including that of non-coding RNA, with near-saturation, thus offering the potential to more fully characterize AOPs and AOP networks. Finally, CRISPR-Cas9 can generate complex animal models in which to conduct preclinical toxicity testing at the level of individual genotypes or haplotypes. Therefore, CRISPR-Cas9 is a powerful and flexible functional genomic screening approach that can be harnessed to provide unprecedented mechanistic insight in the field of modern toxicology.

PubMed ID: 26041264 Exiting the NIEHS site

MeSH Terms: Animals; Bacterial Proteins/genetics*; CRISPR-Associated Protein 9; CRISPR-Associated Proteins/genetics*; CRISPR-Cas Systems*; Endonucleases/genetics*; Environmental Exposure*; Gene Regulatory Networks/drug effects; Gene Silencing; Genetic Testing; Genomics/methods*; Humans; Models, Animal

Back
to Top